arrow
A

Antonio Silvani

Fondazione IRCCS Istituto Neurologico Carlo Besta
H指数:34
被引数:6,005

个人简介

暂无内容

教育背景

暂无内容

工作经历

暂无内容

荣誉奖项

暂无内容

Focused ultrasound-mediated blood-brain barrier opening reshapes plasma extracellular vesicle size distribution without elevating concentration in glioblastoma patients

聚焦超声介导的血脑屏障开放重塑胶质瘤患者血浆外泌体大小分布,而未增加其浓度

2026-07-140
OAAI
Decoding polymorphous low-grade neuroepithelial tumor of the young (PLNTY): Electroclinical features and molecular signatures in epilepsy surgery candidates

青年多形性低级别神经上皮肿瘤(PLNTY)的解读:癫痫手术候选者的电临床特征与分子标志物

2026-06-020
PRE
Diagnostic and predictive molecular biomarkers in brain tumors across the lifespan: an age-stratified consensus statement

脑肿瘤全生命周期中的诊断和预测性分子生物标志物:一份按年龄分层的共识声明

2025-11-240
OAAI
Unique Genetic and Epigenetic Alterations in Glioblastoma Long-Term Survivors: Insights From Two Clinical Cases

胶质母细胞瘤长期生存者的独特遗传和表观遗传改变:来自两个临床病例的见解

2025-10-140
OAAI
A IMPACT OF FRAILTY ON SURGICAL OUTCOMES IN PATIENTS AFFECTED BY GLIOBLASTOMA: A MULTICENTER ANALYSIS WITH MULTIVARIATE AND MACHINE LEARNING APPROACHES.

脆性对受胶质母细胞瘤影响的患者手术结果的影响:一项使用多变量和机器学习方法的多中心分析。

2025-10-010
OA
Education paths in neuro-oncology: combining technical skills with multidisciplinary care. A survey from the AINO (Italian Association for Neuro-Oncology) Youngster Committee

神经肿瘤学的教育路径: 将技术技能与多学科护理相结合。来自AINO (意大利神经肿瘤学协会) 青年委员会的一项调查

2025-03-010
OAAI
Prognostic value of 1D, 2D, and volumetric tumor size increases in recurrent WHO grade 2 and 3 meningiomas: Radiological post-hoc analysis of the EORTC-BTG-1320 trial

1D、2D和容积肿瘤尺寸增加对WHO分级2级和3级复发脑膜瘤的预后价值:EORTC-BTG-1320试验的放射学事后分析

2025-01-010
OAAI
DO PATIENTS WITH MOLECULARLY-DEFINED GLIOBLASTOMA SHARE THE SAME CLINICAL CHARACTERISTICS AND OUTCOME OF HISTOLOGICALLY-DEFINED GLIOBLASTOMA? A MULTICENTRIC STUDY FROM THE ITALIAN ASSOCIATION OF NEURO-ONCOLOGY (AINO)
2024-10-170
PRE
Clinicopathological and molecular landscape of 5-year IDH-wild-type glioblastoma survivors: A multicentric retrospective study
2024-04-010
PRE
The role of adjuvant chemotherapy in patients with H3K27 altered diffuse midline gliomas: a multicentric retrospective study

辅助化疗在H3K27改变的弥漫性中线胶质瘤患者中的作用: 多中心回顾性研究

2024-03-082
PRE
3D volume growth rate evaluation in the EORTC-BTG-1320 clinical trial for recurrent WHO grade 2 and 3 meningiomas

世界卫生组织2级和3级脑膜瘤复发的EORTC-BTG-1320临床试验中的3D体积增长率评估

2024-03-071
PRE